# 2025-16863: FDA Clears Path for Generic NUTRACORT Hydrocortisone Gel Approvals

2025-16863, Determination That NUTRACORT (Hydrocortisone) Topical Gel, 1%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2025-09-03 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-16863
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-16863
- Title: Determination That NUTRACORT (Hydrocortisone) Topical Gel, 1%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 90 FR 42590
- Published: 2025-09-03
- Effective: unknown
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

FDA Clears Path for Generic NUTRACORT Hydrocortisone Gel Approvals

## Summary

The FDA says NUTRACORT hydrocortisone gel, 1%, wasn’t taken off the market because of safety or effectiveness problems. This means drug companies can now get approval to sell generic versions, as long as they follow the rules. People who use or make this gel can expect more options soon, with no extra costs or delays.

## Abstract

The Food and Drug Administration (FDA or Agency) has determined that NUTRACORT (hydrocortisone) topical gel, 1%, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for NUTRACORT (hydrocortisone) topical gel, 1%, if all other legal and regulatory requirements are met.

## Effects PRIA read

- Generic Approvals Allowed for NUTRACORT 1%: benefit, low. If you use NUTRACORT (hydrocortisone) topical gel, 1%, the FDA has determined it was not withdrawn for reasons of safety or effectiveness. That determination lets drugmakers seek approval of abbreviated new drug applications (ANDAs) for NUTRACORT (hydrocortisone) topical gel, 1%, if they meet all o…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2025-16863 on federalregister.gov](https://www.federalregister.gov/documents/2025/09/03/2025-16863/determination-that-nutracort-hydrocortisone-topical-gel-1-was-not-withdrawn-from-sale-for-reasons-of)
- [2025-16863 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-09-03/pdf/2025-16863.pdf)

## Related
- [Previous: 2025-16862, Southern International Co., Ltd., Complainant v. Daynamez Group of Companies LL…](https://policyrisk.com/federal-register/2025-16862)
- [Next: 2025-16864, Taking and Importing Marine Mammals; Taking Marine Mammals Incidental to Geophy…](https://policyrisk.com/federal-register/2025-16864)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-16863 (as of 2026-06-08).
